Can You Feel the Excitement? Kamala Is Back and in the Lead!
Bad News: Abigail Spanberger Is Governor of Virginia. Good News: A Savior Might...
The AI Race Needs a Little More ‘I’ in It
A Republican Who Wants to Raise Taxes
Welcome to the Old World Order
The Midterms: It's Not About 'Affordability' -- It's About Trump Hatred
Trump’s First Year Delivered the Most Meaningful Education Reforms in Decades
Pro-Abortion James Talarico's Factless Campaign for the Senate
How America First Policies Can Lead to Even More Growth in 2026
If You Own It, You Should Be Able to Fix It
Minnesota Malfeasance Is a Preview of Biden-Era Fraud and Waste
Why Children Under 13 Should Be Banned From Social Media
A Refreshing Year for LGBT Conservatives
Jury Convicts Alleged Minneapolis Gang Member in Fatal Gas Station Attack
Former TD Bank Worker Helped Launder $26 Million Through Shell Accounts, Prosecutors Say
Tipsheet

Fauci: Mandating COVID-19 Vaccines for School Children Is a 'Good Idea'

AP Photo/Alex Brandon

White House Chief Medical Adviser Anthony Fauci said Sunday that he would support a COVID-19 vaccine mandate for school students due to the highly contagious delta variant that has resulted in a surge of coronavirus cases across the country.

Advertisement

"I believe that mandating vaccines for children to appear in school is a good idea. We’ve done this for decades and decades, requiring polio, measles, mumps, rubella, hepatitis. So this would not be something new requiring vaccinations for children to come to school," Fauci said Sunday in on CNN’s "State of the Union."

Fauci’s comments come a week after the Food and Drug Administration granted approval to the Pfizer-BioNTech coronavirus vaccine. This approval prompted more than 100 congressional lawmakers last week to call on the FDA to give initial authorization of vaccines for children under 12 as soon as possible.

Advertisement

Fauci, in a different interview on ABC’s "This Week," said that he hopes the FDA will act quickly to approve the jab for children under 12-years-old.

"The data has been collected and we should have enough data by, I would say, the end of September, middle to end of September, early October, so that those data can then be presented to the FDA to examine for the risk benefit ratio of safety and effectiveness," Fauci said.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos